AP NEWS

Cognitive Clinical Trials (CCT) Makes Strides in Alzheimer’s Research With Effective New Model for Patient Recruitment and Retention

October 2, 2018

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oct 2, 2018--As a company dedicated to expediting research related to the treatment and prevention of Alzheimer’s Disease, Cognitive Clinical Trials (CCT) is fundamentally changing the way these types of studies are performed. The company has created a new research model that overcomes the top obstacles facing this research category. “Conducting Alzheimer’s trials presents a different set of challenges,” said CJ Anderson, President of Cognitive Clinical Trials. “We’ve found a way to knock down those barriers to entry for patients, as well as medical providers, so we can move forward with finding a cure.”

CCT’s model brings clinical trials directly to patients who may otherwise be unable to participate due to concerns over travel, scheduling or health conditions. This is accomplished by embedding a clinical research infrastructure within established senior living communities. The infrastructure includes a clinic staffed by physicians, clinical research coordinators and other research professionals.

Through its network of embedded sites, CCT gives trial sponsors an opportunity to collect high quality data in faster and more efficient ways. “We believe this is the first time this has been done,” said CCT’s Chairman of the Board, Paul Lipari. “By partnering with senior living communities, we’re helping the medical field advance Alzheimer’s research while providing residents easy access to professional treatment and care.”

There are currently more than five million Americans living with Alzheimer’s Disease. While there are treatments, there is no cure. CCT offers new hope in the fight against this debilitating disease.

For more information about enrolling yourself or a loved one for a clinical trial, please contact BiancaChacon@cctresearch.com.

Sponsors and senior living communities interested in learning about opportunities to join CCT in the fight for a cure can contact info@cctresearch.com.

About Cognitive Clinical Trials

Cognitive Clinical Trials (CCT) is a company offering an innovative approach to conducting clinical research for the prevention and treatment of Alzheimer’s Disease. CCT embeds research facilities in senior living communities, which simplifies the process for patients and provides sponsors with high quality data. For more information, visit www.cctresearch.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181002005979/en/

CONTACT: Cognitive Clinical Trials

CJ Anderson, 480-702-3501

cjanderson@cctresearch.com

KEYWORD: UNITED STATES NORTH AMERICA ARIZONA

INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS MENTAL HEALTH RESEARCH SCIENCE

SOURCE: Cognitive Clinical Trials

Copyright Business Wire 2018.

PUB: 10/02/2018 02:19 PM/DISC: 10/02/2018 02:19 PM

http://www.businesswire.com/news/home/20181002005979/en

AP RADIO
Update hourly